Event Panel Schedule


Zoom #77 [Zoom]
SPAC or IPO?
Webcast
922c3ff0043dc917081ad15b5ed0342a_77335e84eab89a9defa9f8bcd24b9484_120_120
Credit Suisse
Lorenzo Paoletti , Managing Director / Credit Suisse
Lorenzo Paoletti is a Managing Director in the Healthcare Investment Banking group at Credit Suisse focused on the biopharmaceutical sector. He joined Credit Suisse in 2020 from RBC where he worked in the Healthcare Investment Banking group. He…

Cdc4f64a319b22fca557e551e2937729_f221feedb55d50e9edd4b675fbf0ab34_120_120
Credit Suisse
John F. Hoffman , Managing Director - Life Sciences ECM team / Credit Suisse
John Hoffman is a Managing Director in the Life Sciences Equity Capital Markets group at Credit Suisse. He joined Credit Suisse in 2013 from Lazard.

Ee8b4c071976881506c2f403c7265b3a_b3b0eba52286fa0755e691ccd904e266_120_120
Credit Suisse
Michael Allwin , Director / Credit Suisse
Michael Allwin is a Director in the Healthcare Investment Banking group at Credit Suisse focused on the biopharmaceutical sector. He joined Credit Suisse in 2020 from RBC where he worked in the Healthcare Investment Banking group. He previously…

656c31ead9088b9475ad9fe6a9a9a758_1bcc448b5f5f5951351a1116838ef3dc_120_120
Bain Capital Life Sciences
Andrew Hack, MD, Ph.D. , Managing Director / Bain Capital Life Sciences
Andrew joined Bain Capital Life Sciences in early 2019 from Editas Medicine where he was CFO starting from the summer of 2015. Previously, he served as a portfolio manager at Millennium Management, where he ran a healthcare fund focused on…

6881ea4ca7427ac52d3bc6e796a52f44_2c75a068fbd11752fa8ac1464a87f6dc_120_120
Cooley LLP
Peter Byrne , Special Counsel / Cooley LLP
Peter Byrne represents both issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, secondary and follow-on offerings, debt offerings, debt exchange offers and tender offers and…

5c802ca1456a61949bff06f47b476d76_0b5bba952ecab75757ebe1e5a76aba6a_120_120
Solebury Capital
John Haynor , Managing Director / Solebury Capital
John Haynor is a Managing Director at Solebury Capital where he focuses on the healthcare sector. Before joining Solebury in 2019, John worked in equity capital markets for 15 years most recently as a Managing Director at Jefferies. Prior to…

Zoom #77 [Zoom]
In­cor­po­rate M&A as part of Go­ing Public Pro­cess
Webcast
03ff79ee56ca1914211d3d269c361e1f_c4acb0dfcdbb0ca20f56b6723b1e493b_120_120
Credit Suisse
Jason Jun , Director / Credit Suisse
Jason Jun is a Director at Credit Suisse (2013-present). Previously, he was a Senior Consultant at Deloitte. He received his MBA from Columbia Business School and BSc in Business Management from King’s College London.

01e3480a71d710dce0f72b80e67227c1_2e806bb921873b854961f8858bf10f35_120_120
Credit Suisse
Joshua Pinto, Ph.D , Director / Credit Suisse
Josh Pinto, Ph.D. is a Director in the Healthcare Investment Banking group at Credit Suisse where he covers the life science sector. He joined Credit Suisse in 2015 from Piper Jaffray where he worked in the Healthcare Investment Banking group. Prior…

2702a4410c63e69918f90e14b6a0581c_fd626a6b12a021b1e6ad25d06e88b077_120_120
Credit Suisse
Maneet Singh , Managing Director, M&A / Credit Suisse
Maneet Singh is a Managing Director in the Healthcare M&A Group at Credit Suisse. Maneet is seasoned M&A and strategy professional with significant experience in both Healthcare Services and Pharmaceutical / Life Sciences sectors. He has…

8c749a63e2b5c2c3b6ce403aadf32dec_10b90a96d4ec51b288b501671d0d4f97_120_120
Cooley LLP
Ryan Sansom , Partner / Cooley LLP
Ryan Sansom centers his practice on advising privately held and publicly traded emerging companies, with a strong emphasis on companies across the spectrum of the life sciences industry, including biotechnology, medical devices, healthcare IT and…

8ef01fe922abb27eb124888fecea78cd_c779a95df84ab01ebc57540ea4b0a5f8_120_120
Solebury Trout
Michael Levitan , Managing Director / Solebury Trout
Michael Levitan is a Managing Director based in New York. Since joining the firm in 2007, Michael has worked on a wide variety of investor relations, financing and M&A advisory engagements. Michael has over 20 years of experience in healthcare…
Export to Excel